[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-INCY":3,"homepage-market-summary":31,"stock-stats-INCY":175},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"INCY","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Incyte Genomics Inc","Nasdaq",null,"SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH","Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.","2,844","Wilmington, DE",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},114.13,115.145,115.67,112.83,115.3,-1.17,-1.01,1944434.597729,34303,113.9859,132.6,82.82,1847816.2113405617,62.9,8283,{"status":32,"indices":33,"watchlist":78,"sectors":100,"benchmarks":154},"success",[34,43,50,57,64,71],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":42},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8","2026-10-02",{"symbol":44,"name":45,"price":46,"change":47,"pct_change":48,"is_up":40,"sparkline":49,"date":42},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":51,"name":52,"price":53,"change":54,"pct_change":55,"is_up":40,"sparkline":56,"date":42},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":58,"name":59,"price":60,"change":61,"pct_change":62,"is_up":40,"sparkline":63,"date":42},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":65,"name":66,"price":67,"change":68,"pct_change":69,"is_up":40,"sparkline":70,"date":42},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":72,"name":73,"price":74,"change":75,"pct_change":76,"is_up":14,"sparkline":77,"date":42},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[79,86,93],{"symbol":80,"name":81,"price":82,"change":83,"pct_change":84,"is_up":40,"sparkline":85,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":87,"name":88,"price":89,"change":90,"pct_change":91,"is_up":14,"sparkline":92,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":94,"name":95,"price":96,"change":97,"pct_change":98,"is_up":40,"sparkline":99,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[101,106,110,115,120,125,130,135,140,145,149],{"name":102,"etf":103,"change":104,"price":105,"is_up":40},"Technology","XLK",0.56,200.93,{"name":107,"etf":108,"change":39,"price":109,"is_up":40},"Financials","XLF",53.88,{"name":111,"etf":112,"change":113,"price":114,"is_up":40},"Healthcare","XLV",0.72,167.37,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",0.35,110.42,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.63,81.04,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.99,63.44,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.09,170.1,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",1.31,49.5,{"name":141,"etf":142,"change":143,"price":144,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":146,"etf":147,"change":118,"price":148,"is_up":40},"Utilities","XLU",39.97,{"name":150,"etf":151,"change":152,"price":153,"is_up":40},"Comm Services","XLC",1.17,111.61,[155,160,165,170],{"ticker":156,"name":157,"price":158,"change":159,"is_up":40},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":161,"name":162,"price":163,"change":164,"is_up":40},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":166,"name":167,"price":168,"change":169,"is_up":40},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":171,"name":172,"price":173,"change":174,"is_up":40},"IWM","iShares Russell 2000",283.39,0.66,{"ticker":4,"company_name":7,"current_price":16,"data_notice":176,"valuation":177,"dates":180,"share_statistics":182,"valuation_ratios":185,"enterprise_valuation":186,"financial_position":187,"financial_efficiency":189,"taxes":191,"price_statistics":192,"income_statement":199,"balance_sheet":201,"cash_flow":202,"margins":204,"dividends":205,"analyst_forecast":207,"fair_value":209,"splits":211,"fundamentals_available":14},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":178,"enterprise_value":9,"summary":179},23371050113.8,"INCY has a market cap of $23,371,050,113.80.",{"latest_fiscal_period_end":9,"earnings_date":9,"ex_dividend_date":9,"summary":181},"No fundamental filing dates are available for this symbol.",{"shares_outstanding":183,"owned_by_insiders":9,"owned_by_institutions":9,"summary":184},202697746,"INCY has 202,697,746 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":9,"pfcf_ratio":9,"pocf_ratio":9},{"ev_earnings":9,"ev_sales":9,"ev_ebitda":9,"ev_ebit":9,"ev_fcf":9},{"current_ratio":9,"debt_equity":9,"debt_ebitda":9,"debt_fcf":9,"summary":188},"Balance sheet data is not available for this symbol.",{"roe":9,"roa":9,"revenue_per_employee":9,"profit_per_employee":9,"employee_count":190,"asset_turnover":9},2844,{"income_tax":9},{"beta_5y":9,"price_change_52w":193,"ma_50":194,"ma_200":195,"rsi_14":196,"avg_volume_20d":197,"summary":198},31.41,123.55,106.94,35.25,1665628,"The stock price has changed by +31.41% in the last 52 weeks.",{"revenue":9,"gross_profit":9,"operating_income":9,"pretax_income":9,"net_income":9,"ebitda":9,"ebit":9,"eps":9,"summary":200},"Income statement data is not available for this symbol.",{"cash_and_equiv":9,"total_debt":9,"net_cash":9,"net_cash_per_share":9,"equity_book_value":9,"book_value_per_share":9,"working_capital":9,"summary":188},{"operating_cash_flow":9,"capital_expenditures":9,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":9,"fcf_per_share":9,"summary":203},"Cash flow data is not available for this symbol.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":9,"dividend_yield":9,"earnings_yield":9,"fcf_yield":9,"summary":206},"INCY has no recorded dividend payments.",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":208},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":210},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":212},"Stock split history is not available for this symbol."]